Valhi, Inc. (VHI)
NYSEMaterialsChemicalsSnapshot 2026-09-09
$18.34-1.71%
Close 2026-09-09 · 1-day change
NYSEMaterialsChemicalsSnapshot 2026-09-09
Intact: The reason to own it still holds.
Valhi grew revenue from $494.5M to $560.1M in one quarter. Profit turned positive to $2M from a $53.2M loss. The company aims to improve profits and revenue. Dividend payments support cash flow outlook.
Valhi is still loss-making and cash flow is unstable. Revenue may shrink about 4% next year. Profit gains might not last if cash flow stays weak.
The market expects about 4% revenue decline next year. Our fair value is near $75, showing some upside if turnaround succeeds.
Breaks if: Cash flow stays negative next 4 quarters
Focus on improving cash flow from operations and managing liquidity despite fluctuations in operating cash generation.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on improving profitability and revenue growth. The current thesis state indicates mixed progress, with management actively working on key priorities but facing challenges in cash flow management.
The market seems to have priced in a level of fragility in VHI's execution, as indicated by its expensive valuation relative to peers. There is an expectations gap, suggesting that investors are cautious about future performance.
Management has made strides in improving operating income and revenue growth, but cash flow generation remains inconsistent. The near-term risk of an earnings miss is elevated, with a significant probability of falling short in upcoming quarters.
The long-term thesis hinges on management's ability to maintain profitability improvements and navigate cash flow challenges. Additionally, external factors such as inflation trends and sector performance will play a critical role in shaping VHI's future.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Cash from operating activities showed volatility, rising to $100.6 million in 2025-Q4 but declining to negative $46.1 million in 2026-Q1. Management continues to focus on managing cash flow and liquidity, but the trajectory shows mixed progress.
“Cash from operating activities was $100.6 million in 2025-Q4 but negative $46.1 million in 2026-Q1, reflecting volatility in cash generation.”
“Cash from operating activities was negative $46.1 million in 2026-Q1, highlighting challenges in cash flow management.”
Breaks if: Net income falls below zero next quarter
Focus on increasing operating income and profitability across Chemicals, Component Products, and Real Estate segments through cost reductions and operational efficiency.
Stated as a priority in 2 of last 2 quarters. Chemicals Segment operating income rose from $10.3 million in 2025-Q2 to $40.4 million in 2026-Q2, with total operating income increasing from $67.7 million in 2026-Q1 to $100.6 million in 2026-Q2. Management's cost reduction initiatives and operational efficiency efforts are delivering improved profitability.
“Chemicals Segment operating income increased to $40.4 million in Q2 2026 from $10.3 million in Q2 2025 due to cost reductions and operational efficiency.”
“Cost reduction initiatives implemented in Q4 2025 designed to permanently improve Chemicals Segment cost structure and efficiency.”
Breaks if: Operating income falls below zero next quarter
Focus on increasing operating income and profitability across Chemicals, Component Products, and Real Estate segments through cost reductions and operational efficiency.
Stated as a priority in 2 of last 2 quarters. Chemicals Segment operating income rose from $10.3 million in 2025-Q2 to $40.4 million in 2026-Q2, with total operating income increasing from $67.7 million in 2026-Q1 to $100.6 million in 2026-Q2. Management's cost reduction initiatives and operational efficiency efforts are delivering improved profitability.
“Chemicals Segment operating income increased to $40.4 million in Q2 2026 from $10.3 million in Q2 2025 due to cost reductions and operational efficiency.”
“Cost reduction initiatives implemented in Q4 2025 designed to permanently improve Chemicals Segment cost structure and efficiency.”
Breaks if: Revenue falls below $494.5M next quarter
Drive revenue growth primarily through market share gains and pricing improvements in Chemicals and Component Products segments.
Stated as a priority in 2 of last 2 quarters. Chemicals Segment net sales grew 13% from $494.4 million in 2025-Q2 to $558.1 million in 2026-Q2, and Component Products sales increased from $40.3 million to $43.6 million over the same period. Revenue growth is delivering consistent progress aligned with management's statements.
“Chemicals Segment net sales of $558.1 million in Q2 2026 were 13% higher than Q2 2025; Component Products net sales increased to $43.6 million.”
“Chemicals Segment net sales increased 4% in Q1 2026 compared to Q1 2025 due to higher sales volumes and favorable currency impacts.”
Overall, VHI presents a complex picture with potential for recovery but significant risks ahead. Not investment advice.